P0DTG1 orf3C
P0DTD8 orf7B
P0DTD3 orf9c
P0DTD2 orf9b
P0DTD1 orf1ab
P0DTC9 geneN
P0DTC8 orf8
P0DTC7 orf7A
P0DTC6 orf6
P0DTC5 geneM
P0DTC4 geneE
P0DTC3 orf3a
P0DTC2 spike
P0DTC1 orf1a
orf1a	154	180	Region	Note=Binding to 40s ribosome mRNA entry channel;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32680882;Dbxref=PMID:32680882
orf1a	926	999	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
orf1a	180	181	Site	Note=Cleavage%3B by PL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	818	819	Site	Note=Cleavage%3B by PL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	2763	2764	Site	Note=Cleavage%3B by PL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	3263	3264	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	3569	3570	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	3859	3860	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	3942	3943	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	4140	4141	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	4253	4254	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	4392	4393	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1a	154	157	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. YEDF->AEDA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32908316;Dbxref=PMID:32908316
orf1a	164	165	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. KH->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32908316;Dbxref=PMID:32908316
orf1a	164	164	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32680882;Dbxref=PMID:32680882
orf1a	165	165	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32680882;Dbxref=PMID:32680882
orf1a	171	175	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. RELMR->EELME;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32908316;Dbxref=PMID:32908316
orf1a	1629	1629	Mutagenesis	Note=Partial loss of ISG15 cleavage in vitro. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1a	1632	1632	Mutagenesis	Note=Partial loss of ISG15 cleavage in vitro. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1a	1638	1638	Mutagenesis	Note=Partial loss of ubiquitin cleavage in vitro%3B no effect on ISG15 cleavage in vitro. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1a	1638	1638	Mutagenesis	Note=Increased cleavage of ubiquitin in vitro%3B no effect on ISG15 cleavage in vitro. T->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1a	1674	1674	Mutagenesis	Note=Complete loss of PL-pro activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1a	1831	1831	Mutagenesis	Note=Reduced inhibition by GRL-0617. Y->G%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
spike	13	303	Domain	Note=BetaCoV S1-NTD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01270
spike	334	527	Domain	Note=BetaCoV S1-CTD;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU01269,ECO:0000269|PubMed:32132184;Dbxref=PMID:32132184
spike	319	541	Region	Note=Receptor-binding domain (RBD);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32132184;Dbxref=PMID:32132184
spike	403	405	Region	Note=Integrin-binding motif%3B;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33102950;Dbxref=PMID:33102950
spike	437	508	Region	Note=Receptor-binding motif%3B binding to human ACE2;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P59594
spike	816	837	Region	Note=Fusion peptide 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04099
spike	835	855	Region	Note=Fusion peptide 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04099
spike	920	970	Region	Note=Heptad repeat 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04099
spike	1163	1202	Region	Note=Heptad repeat 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04099
spike	1269	1273	Motif	Note=KxHxx;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04099
spike	685	686	Site	Note=Cleavage%3B by TMPRSS2 or furin;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32142651,ECO:0000269|PubMed:32362314;Dbxref=PMID:32142651,PMID:32362314
spike	815	816	Site	Note=Cleavage%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04099
spike	17	17	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32366695,PMID:32979942
spike	61	61	Glycosylation	Note=N-linked (GlcNAc...) (hybrid) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	74	74	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32363391,PMID:32366695,PMID:32979942
spike	122	122	Glycosylation	Note=N-linked (GlcNAc...) (hybrid) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	149	149	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32363391,PMID:32366695,PMID:32979942
spike	165	165	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	234	234	Glycosylation	Note=N-linked (GlcNAc...) (high mannose) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	282	282	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	323	323	Glycosylation	Note=O-linked (GalNAc) threonine%3B by host;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32363391;Dbxref=PMID:32363391
spike	325	325	Glycosylation	Note=O-linked (HexNAc...) serine%3B by host;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32363391;Dbxref=PMID:32363391
spike	331	331	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	343	343	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	603	603	Glycosylation	Note=N-linked (GlcNAc...) (hybrid) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32366695,PMID:32979942
spike	616	616	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	657	657	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	709	709	Glycosylation	Note=N-linked (GlcNAc...) (high mannose) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	717	717	Glycosylation	Note=N-linked (GlcNAc...) (hybrid) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	801	801	Glycosylation	Note=N-linked (GlcNAc...) (hybrid) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	1074	1074	Glycosylation	Note=N-linked (GlcNAc...) (hybrid) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	1098	1098	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32363391,PMID:32366695,PMID:32979942
spike	1134	1134	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32155444,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32155444,PMID:32366695,PMID:32979942
spike	1158	1158	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32366695,PMID:32979942
spike	1173	1173	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32366695,PMID:32979942
spike	1194	1194	Glycosylation	Note=N-linked (GlcNAc...) (complex) asparagine%3B by host;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|HAMAP-Rule:MF_04099,ECO:0000269|PubMed:32363391,ECO:0000269|PubMed:32366695,ECO:0000269|PubMed:32979942;Dbxref=PMID:32363391,PMID:32366695,PMID:32979942
spike	234	234	Mutagenesis	Note=Increased resistance to neutralizing antibodies. N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	331	331	Mutagenesis	Note=Reduced viral infectivity. N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	343	343	Mutagenesis	Note=Reduced viral infectivity. N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	452	452	Mutagenesis	Note=Increased resistance to neutralizing antibodies. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	475	475	Mutagenesis	Note=Increased resistance to neutralizing antibodies. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	483	483	Mutagenesis	Note=Increased resistance to neutralizing antibodies. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	490	490	Mutagenesis	Note=Increased resistance to neutralizing antibodies and human covalescent sera neutralization. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	493	493	Mutagenesis	Note=Reduced host ACE2-binding affinity in vitro. Q->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32225175;Dbxref=PMID:32225175
spike	493	493	Mutagenesis	Note=Reduced host ACE2-binding affinity in vitro. Q->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32225175;Dbxref=PMID:32225175
spike	501	501	Mutagenesis	Note=Reduced host ACE2-binding affinity in vitro. N->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32225175;Dbxref=PMID:32225175
spike	519	519	Mutagenesis	Note=Increased resistance to human covalescent sera neutralization. H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32730807;Dbxref=PMID:32730807
spike	614	614	Mutagenesis	Note=Increase of pseudotyped VSV particle production ex vivo. Increase of viral load in hamster upper respiratory tract. Produces more infectious particles when cultured in primary human epithelial cells%3B increases replication and transmissibility in hamsters and ferrets. D->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:32697968,ECO:0000269|PubMed:33106671,ECO:0000269|PubMed:33636719;Dbxref=PMID:32697968,PMID:33106671,PMID:33636719
spike	679	684	Mutagenesis	Note=About 50%25 stronger entry efficiency in Vero E6 cells while 30%25 weaker entry efficiency in hACE2-expressing BHK cells. NSPRRA->IL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32155444;Dbxref=PMID:32155444
spike	681	684	Mutagenesis	Note=Optimized cleavage by host furin. PRRA->RRRK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32362314;Dbxref=PMID:32362314
spike	682	684	Mutagenesis	Note=Complete loss of cleavage by host furin. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32362314;Dbxref=PMID:32362314
orf3a	33	141	Domain	Note=CoV 3a-like viroporin TM;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01311
orf3a	145	237	Domain	Note=CoV 3a-like viroporin CD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01312
orf3a	133	133	Site	Note=Involved in polymerization;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P59632
orf3a	32	32	Glycosylation	Note=O-linked (GalNAc...) threonine%3B by host;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P59632
orf3a	34	34	Glycosylation	Note=O-linked (GalNAc...) threonine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255
geneE	72	75	Motif	Note=PDZ-binding%3B required for interaction with human MPP5;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P59637
orf6	58	58	Mutagenesis	Note=Complete loss of binding to the NUP98-RAE1 complex and IFN antagonistic function. M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33097660;Dbxref=PMID:33097660
orf7A	16	81	Domain	Note=X4e;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01267
orf7A	117	121	Motif	Note=Di-lysine motif;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P59635
orf7A	2	2	Mutagenesis	Note=No effect on ubiquitination. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
orf7A	32	32	Mutagenesis	Note=No effect on ubiquitination. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
orf7A	53	53	Mutagenesis	Note=No effect on ubiquitination. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
orf7A	72	72	Mutagenesis	Note=No effect on ubiquitination. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
orf7A	85	85	Mutagenesis	Note=No effect on ubiquitination. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
orf7A	117	117	Mutagenesis	Note=No effect on ubiquitination. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
orf7A	119	119	Mutagenesis	Note=Complete loss of ubiquitination. Partial loss of interferon pathway inhibition. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:33473190;Dbxref=PMID:33473190
geneN	48	174	Domain	Note=CoV N NTD;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU01276,ECO:0000269|PubMed:32363136;Dbxref=PMID:32363136
geneN	247	364	Domain	Note=CoV N CTD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01277
geneN	1	51	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
geneN	41	186	Region	Note=RNA-binding;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04096
geneN	63	83	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
geneN	168	212	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
geneN	233	266	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
geneN	258	361	Region	Note=Dimerization;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04096
geneN	361	391	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
geneN	109	109	Mutagenesis	Note=Significant decrease of RNA binding capacity. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32363136;Dbxref=PMID:32363136
orf1ab	154	180	Region	Note=Binding to 40s ribosome mRNA entry channel;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:32680882,ECO:0000269|PubMed:32908316;Dbxref=PMID:32680882,PMID:32908316
orf1ab	926	999	Region	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite
orf1ab	4937	4947	Region	Note=Interaction with RMP Remdesivir;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32358203;Dbxref=PMID:32358203
orf1ab	6256	6262	Region	Note=SAM-binding;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01299
orf1ab	6339	6353	Region	Note=GpppA-binding;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01299
orf1ab	180	181	Site	Note=Cleavage%3B by PL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	818	819	Site	Note=Cleavage%3B by PL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	2763	2764	Site	Note=Cleavage%3B by PL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	3263	3264	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	3569	3570	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	3859	3860	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	3942	3943	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	4140	4141	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	4253	4254	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	4392	4393	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	5324	5325	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	5925	5926	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	6452	6453	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	6798	6799	Site	Note=Cleavage%3B by 3CL-PRO;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0C6V3
orf1ab	154	157	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. YEDF->AEDA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32908316;Dbxref=PMID:32908316
orf1ab	164	165	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. KH->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32908316;Dbxref=PMID:32908316
orf1ab	164	164	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32680882;Dbxref=PMID:32680882
orf1ab	165	165	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32680882;Dbxref=PMID:32680882
orf1ab	171	175	Mutagenesis	Note=Complete loss of ribosome binding and cellular translation inhibition. RELMR->EELME;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32908316;Dbxref=PMID:32908316
orf1ab	1629	1629	Mutagenesis	Note=Partial loss of ISG15 cleavage in vitro. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1ab	1632	1632	Mutagenesis	Note=Partial loss of ISG15 cleavage in vitro. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1ab	1638	1638	Mutagenesis	Note=Partial loss of ubiquitin cleavage in vitro%3B no effect on ISG15 cleavage in vitro. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1ab	1638	1638	Mutagenesis	Note=Increased cleavage of ubiquitin in vitro%3B no effect on ISG15 cleavage in vitro. T->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1ab	1674	1674	Mutagenesis	Note=Complete loss of PL-pro activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1ab	1831	1831	Mutagenesis	Note=Reduced inhibition by GRL-0617. Y->G%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32726803;Dbxref=PMID:32726803
orf1ab	5253	5253	Mutagenesis	Note=Reduces RdRp inhibition by remdesivir. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32526208;Dbxref=PMID:32526208
orf9b	8	97	Domain	Note=9b;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01268
orf9b	45	53	Motif	Note=Nuclear export signal;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P59636
